Bright Minds Biosciences Inc
DRUG
Get informed when a big investor buys or sells
+ FollowMarket Cap$510.63M
Close$
$8.49
87.4% downside
Current Fair Value
87.4% downsideOvervalued by 87.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $510.63 Million |
|---|---|
| Enterprise Value | $201.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.78 |
| Beta | -0.11 |
| Outstanding Shares | 9,589,842 |
Return
| Return on Equity | -8.55% |
|---|---|
| Return on Assets | -8.45% |
| Return on Invested Capital | -8.51% |
Valuation & Multiples
| P/E Ratio | -26.43 |
|---|---|
| PEG | -10.15 |
| Price to Sales | - |
| Price to Book Ratio | 2.11 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.67 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-1.17
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-1.28
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 118.39%▲ 33.48% |
|---|---|
| Total Invested | $670.28M▲ 30.17% |
| Investors Holding | 94▲ 20.00% |
ESG Score
No data